KARI 101
KARI 101 is a blood-brain barrier permeable acid sphingomyelinase (ASM) inhibitor. KARI 101 directly inhibits ASM activity and reduces ceramide production. KARI 101 induces Ca2+ mobilization, activates AMPK and triggers GHSR1α internalization. KARI 101 can be used for the research of Alzheimer's disease.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 3061559-97-2
- Formel: C15H30N4O2
- Molecular Weight:298.42
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Alle AMPK Isoform-spezifische Produkte anzeigen
MoreAlle Calcium Channel Isoform-spezifische Produkte anzeigen
More
Biologische Aktivität
KARI 101 binds to purified acid sphingomyelinase (ASM) protein with high affinity[1].
KARI 101 inhibits the activity of secretory acid sphingomyelinase (ASM) in the supernatant of fibroblasts from PS1 familial Alzheimer's disease[1].
KARI 101 acts as a potent GHSR1α agonist in HEK293A cells overexpressing GHSR1α, with an EC50 of 188.5 nM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS. Nr. 3061559-97-2
-
Molecular Weight 298.42
-
Formel C15H30N4O2
-
SMILES
OCC(C1=CN(CCCCCCCCCC)N=N1)(CO)N
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)